Animal models in oral cancer research

Oral Oncology

Volumn 42, Issue 5, 2006, Pages 448-460

  Mognetti, B ^a   Di Carlo, F ^a   Berta, G N ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Animal models; Chemical induction; Oral cancer; Transgenic animals; Transplanted tumors

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; CANCER GRAFT; CANCER GROWTH; CANCER MORTALITY; CANCER RESEARCH; CANCER TRANSPLANTATION; CARCINOGENESIS; COCARCINOGENESIS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EVALUATION; GENE INDUCTION; IN VIVO STUDY; KNOCKOUT GENE; METASTASIS; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; TRANSGENIC ANIMAL; TREATMENT PLANNING;

ANIMALS; CARCINOMA, SQUAMOUS CELL; COCARCINOGENESIS; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 33646143993     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.07.014     Document Type: Review

References (172)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Reid B.C., Winn D.M., Morse D.E., and Pendrys D.G. Head and neck in situ carcinoma: incidence, trends, and survival. Oral Oncol 36 (2000) 414-420
3. Grupta P.C. Mouth cancer in India: a new epidemic?. J Indian Med Assoc 97 (1999) 370-373
4. Macfarlane G.J., Boyle P., Evstifeeva T.V., Robertson C., and Scully C. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 5 (1994) 259-265
5. Muir C., and Weiland L. Upper aerodigestive tract cancers. Cancer 75 (1995) 147-153
6. Funk G.F., Karnell L.H., Robinson R.A., Zhen W.K., Trask D.K., and Hoffman H.T. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24 (2002) 165-180
7. Kosary GL, Ries LAG, Miller BA, Hankey BF, Harrasa A, Edwards BK, editors. SEER cancer statistics review, 1973-1992: tables and graphs. NIH pub. No. 96-2789. Bethesda: National Cancer Institute, 1995.
8. Berrino F, Sant M, Verdecchia A, Capocaccia Hakulinene T, Esteve J. Survival of cancer patients in Europe: the EURO-CARE study. Lyon: IARC Scientific publication No. 132. International Agency for Research on Cancer, 1995.
9. Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries. IARC Scientific publication No. 145 Lyon. International Agency for Research on cancer, 1998.
10. Day G.L., and Blot W.J. Second primary tumors in patient with oral cancer. Cancer 70 (1992) 14-19
11. van der Tol I.G., de Visscher J.G., Jovanovic A., and van der Waal I. Risk of second primary cancer following treatment of squamous cell carcinoma of the lower lip. Oral Oncol 35 (1999) 571-574
12. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
13. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 (2001) 1125-1131
14. Kuriakose M., Sankaranarayanan M., Nair M.K., et al. Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol 28B (1992) 113-120
15. Schantz S.P., Byers R.M., Goepfert H., Shallenberger R.C., and Beddingfield N. The implication of tobacco use in the young adult with head and neck cancer. Cancer 62 (1988) 1374-1380
16. Grasso P., and Mann A.H. Smokeless tobacco and oral cancer: an assessment of evidence derived from laboratory animals. Food Chem Toxicol 36 (1998) 1015-1029
17. Eveson J.W. Animal models of intra-oral chemical carcinogenesis: a review. J Oral Pathol 10 (1981) 129-146
18. Homburger F. Chemical carcinogenesis in the Syrian golden hamster. A review. Cancer 23 (1969) 313-338
19. Hawkins B.L., Heniford B.W., Ackermann D.M., Leonberger M., Martinez S.A., and Hendler F.J. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck 16 (1994) 424-432
20. Thurman J.D., Greenman D.L., Kodell R.L., and Turturro A. Oral squamous cell carcinoma in ad libitum-fed and food-restricted Brown-Norway rats. Toxicol Pathol 25 (1997) 217-224
21. Hier M.P., Black M.J., Shenouda G., Sadeghi N., and Karp S.E. A murine model for the immunotherapy of head and neck squamous cell carcinoma. Laryngoscope 105 (1995) 1077-1080
22. Schultz-Hector S., and Haghayegh S. Beta-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 53 (1993) 1444-1449
23. Gardner D.G. Spontaneous squamous cell carcinomas of the oral region in domestic animals: a review and consideration of their relevance to human research. Oral Dis 2 (1996) 148-154
24. Hoffmann D., and Djordjevic M.V. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 11 (1997) 322-329
25. Hoffmann D., Brunnemann K.D., Prokopczyk B., and Djordjevic M.V. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 41 (1994) 1-52
26. Mattson M.E., Winn D.M., Ogden G.R., and Wight A.J. Aetiology of oral cancer: alcohol. Br J Oral Maxillofac Surg 36 (1998) 247-251
27. Levy B.M., Gorlin R., and Gottsegen R. A histologic study of the reaction of skin and mucous membrane to a single application of 9,10 dimethyl-1,2,benzanthracene. J Dent Res 29 (1950) 678-679
28. Nishioka H., Hishi K., and Kyokane K. Human saliva inactivates mutagenicity of carcinogens. Mutat Res 85 (1981) 323-333
29. Dayan D., Hirshberg A., and Kaplan I. Experimental tongue cancer in desalivated rats. Oral Oncol 33 (1997) 105-109
30. Keyes P.H., and Dale P.P. A preliminary survey of the pouches and dentition of the Syrian hamster. J Dent Res 23 (1944) 427-438
31. Salley J.J. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 33 (1954) 253-262
32. Morris A.L. Factors influencing experimental carcinogenesis in the hamster cheek pouch. J Dent Res 40 (1961) 3-15
33. Lin L.M., Chen Y.K., Lai D.R., and Huang Y.L. Minimal arecaidine concentrations showing a promotion effect during DMBA-induced hamster cheek pouch carcinogenesis. J Oral Pathol Med 25 (1996) 65-68
34. Ashby F., Styles J.A., and Boyland E. Betel nuts, arecaidine and oral cancer. Lancet 1 (1979) 112
35. Wani M.K., Yarber R.H., Ahmed A., Hengesteg A., and Robbins K.T. Cancer induction in the DMBA Hamster cheek pouch: a modified technique using a promoter. Laryngoscope 111 (2001) 204-206
36. Kim T.W., Chen Q., Shen X., et al. Oral mucosal carcinogenesis in SENCAR mice. Anticancer Res 22 (2002) 2733-2740
37. Heller B., Kluftinger A.M., Davis N.L., and Quenville N.F. A modified method of carcinogenesis induction in the DMBA hamster cheek pouch model of squamous neoplasia. Am J Surg 172 (1996) 678-680
38. Salley J.J. Histologic changes in the hamster cheek pouch during early hydrocarbon carcinogenesis. J Dent Res 36 1 (1957) 48-55
39. Salley J.J., and Kreshover S.J. The effect of topical application of carcinogens on the palatal mucosa of the hamster. Oral Surg Oral Med Oral Pathol 12 4 (1959) 501-508
40. IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 37. Lyon: International Agency for Research on Cancer; 1985.
41. Sen S., Talukder G., and Sharma A. Betel cytotoxicity. J Ethnopharmacol 26 (1989) 217-247
42. Jeng J.H., Chang M.C., and Hahn L.J. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37 (2001) 477-492
43. Chiang C.P., Chang M.C., Lee J.J., et al. Hamsters chewing betel quid or areca nut directly show a decrease in body weight and survival rates with concomitant epithelial hyperplasia of cheek pouch. Oral Oncol 40 (2004) 720-727
44. Mori M., Miyaji T., Murata I., and Nagasuna H. Histochemical observations on enzymatic processes of experimental carcinogenesis in hamster cheek pouch. Cancer Res 22 (1962) 1323-1326
45. Solt D.B. Localization of gamma-glutamyl transpeptidase in hamster buccal pouch epithelium treated with 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 67 (1981) 193-200
46. Lurie A.G., Rozenski D.L., and Coghill J.E. DNA adduct formation by 7,12-dimethylbenz(a)anthracene in Syrian hamster cheek pouch epithelium in vivo. Cancer Res 48 (1988) 2025-2028
47. Gimenez-Conti I.B., Bianchi A.B., Stockman S.L., Conti C.J., and Slaga T.J. Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch. Mol Carcinog 5 (1992) 259-263
48. Chang K.W., Lin S.C., Koos S., Pather K., and Solt D. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis 17 (1996) 595-600
49. Chen Y.K., Huse S.S., and Lin L.M. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Int J Exp Pathol 85 (2004) 97-104
50. Shklar G., and Schwartz J.L. Oral cancer inhibition by micronutrients. The experimental basis for clinical trials. Eur J Cancer B Oral Oncol 29 (1993) 9-16
51. Shklar G., and Schwartz J.L. A common pathway for the destruction of cancer cells: experimental evidence and clinical implications. Int J Cancer 4 (1994) 215-224
52. Shklar G. Experimental oral pathology in the Syrian hamster. Prog Exp Tumor Res 16 (1972) 518-538
53. Gimenz-Conti I.B., and Slaga T. The hamster cheek pouch carcinogenesis model. J Cell Biochem 17 (1993) 83-90
54. Shklar G., and Schwartz J.L. Comparison of experimental hamster tongue and buccal pouch carcinomas and carcinogenesis. Int J Oral Biol 23 (1998) 71-74
55. Marefat M.P., and Shklar G. Experimental production of lingual leukoplakia and carcinoma. Oral Surg, Oral Med, Oral Path 44 (1977) 578-586
56. Gimenz-Conti I.B., La Bate M., and Osterndorff E. p53 alterations in chemically induced hamster cheek pouch lesions. Mol Carcinogenesis 16 (1996) 197-202
57. Schwartz J.L., and Shklar G. Verification in syngeneic hamsters of in vitro transformation of hamster oral mucosa by 7,12-dimethylbenz(a)anthracene. Eur J Cancer 33 (1997) 431-438
58. Wong D.T.W., Gertz R., Chow P., et al. Detection of K-ras mRNA in normal and chemically transformed hamster oral keratinocytes. Cancer Res 49 (1989) 4562-4567
59. Robles A.I., Gimenz-Conti I.B., Roop D., Slaga T.G., and Conti C.J. Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz(a)anthracene-induced hamster skin lesions. Mol Carcinogenesis 7 (1993) 94-98
60. Wong D.T.W. Amplification of the c-erbB1 oncogene in chemically-induced oral carcinomas. Carcinogenesis 8 (1987) 963-967
61. Husain Z., Fei Y., Roy S., Solt D.B., Polverini P., and Biswas D.K. Sequential expression and cooperation interaction of c-Ha-ras and c-erbB genes in in vivo carcinogenesis. Proc Natl Acad Sci USA 86 (1989) 1264-1268
62. Schwartz J.L., Antoniades D.Z., and Zhao S. Molecular and biochemical reprogramming of oncogenesis thru the activity of antioxidants and prooxidants. Ann NY Acad Sci 128 (1989) 262-279
63. Schwartz J.L. Molecular and biochemical control of tumor growth following treatment with carotenoids and tocopherols. In: Prasad K., Santamaria L., and Williams R.M. (Eds). Nutrition and cancer prevention and treatment (1995), Humana Press, New Jersey 287-316
64. Suda D., Schwartz J.L., and Shklar G. GGT reduction in beta carotene inhibition of hamster buccal pouch carcinogenesis. Eur J Cancer Clin Oncol 23 (1987) 43-46
65. Schwartz J.L., West K., Shklar D.P., and Shklar G. Altered cytokeratin expression in carcinogenesis inhibition by antioxidant nutrients. Nutr Cancer 24 (1995) 47-56
66. Gimenz-Conti I.B., Shin D.M., Bianchi A.B., et al. Changes in keratin expression during 7,12-dimethylbenz(a)anthracene induced hamster cheek pouch carcinogenesis. Cancer Res 50 (1990) 4441-4445
67. Schwartz J.L., Flynn E., and Shklar G. The effect of carotenoids on the antitumor immune response in vitro and in vitro with hamster and mouse immune effectors. Ann NY Acad Sci 587 (1990) 92-109
68. Schwartz J.L., Sloane D., and Shklar G. Prevention and inhibition of oral cancer in the hamster buccal pouch model associated with carotenoid immune enhancement. Tumor Biol 10 (1989) 297-309
69. Schwartz J.L., Flynn D., and Shklar G. Directed lysis of experimental cancer by β-carotene in liposomes. Nutrition Cancer 16 (1991) 107-124
70. Wong D.T.W., Gallagher G.T., Gertz R., Change A.L.C., and Shklar G. Transforming growth a in chemically transformed hamster oral keratinocytes. Cancer Res 48 (1988) 3130-3134
71. Wong D.T.W. TGF and oral carcinogenesis. Oral Oncol 29 (1993) 3-7
72. Schwartz J.L., and Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr Cancer 26 (1996) 229-236
73. Shklar G., and Schwartz J.L. Vitamin E inhibits experimental carcinogenesis and tumor angiogenesis. Oral Oncol Eur J Cancer 32 (1996) 114-119
74. Suda D., Schwartz J.L., and Shklar G. Inhibition of experimental oral carcinogenesis by topical beta carotene. Carcinogenesis 7 (1986) 711-715
75. Shklar G., Schwartz J.L., and Trickler D. Regression of experimental cancer by oral administration of combined alpha-tocopherol, and beta carotene. Nutr Cancer 12 (1989) 321-324
76. Shklar G. Inhibition of oral mucosal carcinogenesis by vitamin E. J Natl Cancer Inst 68 (1982) 791-797
77. Shklar G., Schwartz J.L., Trickler D., and Chervie S.R. The effectiveness of a mixture of βcarotene, αtocopherol, glutathione, and ascorbic acid for cancer prevention. Nutr Cancer 20 (1993) 145-151
78. Walker F., Carter J., Crawford G.P., Laird H., Lessells A.M., and Pollet J.E. Hamster cheek pouch mucosubstances and immunological privilege. Br J Exp Pathol 51 (1970) 379-384
79. MacDonald D.G. Comparison of epithelial dysplasia in hamster cheek pouch carcinogenesis and human oral mucosa. J Oral Pathol 10 (1981) 186-191
80. Nauta J.M., Roodenburg J.L., Nikkels P.G., Witjes M.J., and Vermey A. Comparison of epithelial dysplasia-the 4NQO rat palate model and human oral mucosa. Int J Oral Maxillofac Surg 24 (1995) 53-58
81. Pathak I., Davis N.L., Hsiang Y.N., Quenville N.F., and Palcic B. Detection of squamous neoplasia by fluorescence imaging comparing porfimer sodium fluorescence to tissue autofluorescence in the hamster cheek-pouch model. Am J Surg 170 (1995) 423-426
82. Wang C.Y., Tsai T., Chen H.C., Chang S.C., Chen C.T., and Chiang C.P. Autofluorescence spectroscopy for in vivo diagnosis of DMBA-induced hamster buccal pouch pre-cancers and cancers. J Oral Pathol Med 32 (2003) 18-24
83. Dhingra J.K., Zhang X., McMillan K., et al. Diagnosis of head and neck precancerous lesions in an animal model using fluorescence spectroscopy. Laryngoscope 108 (1998) 471-475
84. Wallenius K., and Lekholm U. Oral cancer in rats induced by the water-soluble carcinogen 4-nitrochinoline N-oxide. Odontol Rev 24 (1973) 39-48
85. Steidler N.E., and Reade P.C. Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinolone-1-oxide. Oral Surg Oral Med Oral Pathol 57 (1984) 524-531
86. Wong P.N., and Wilson D.F. 4 Nitroquinoline 1-oxide-induced carcinogenesis in the rat palate. J Oral Pathol 12 (1983) 375-384
87. Nauta J.M., Roodenburg J.L., Nikkels P.G., Witjes M.J., and Vermey A. Epithelial dysplasia and squamous cell carcinoma of the Wistar rat palatal mucosa: 4NQO model. Head Neck 18 (1996) 441-449
88. Steidler N.E., Rich A.M., and Reade P.C. Experimental induction of preneoplastic and neoplastic changes in the lingual mucosa of rats. J Biol Buccale 13 (1985) 339-346
89. Tang X.H., Knudsen B., Bemis D., Tickoo S., and Gudas L.J. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 10 (2004) 301-313
90. Yuan B., Heniford B.W., Ackermann D.M., Hawkins B.L., and Hendler F.J. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res 54 (1994) 5310-5317
91. Nishimura A. Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J Dent Res 78 (1999) 1264-1269
92. Osugi Y. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. J Osaka Dent Univ 30 (1996) 29-35
93. Sakaki T., Tamura I., Kadota H., and Kakudo K. Changing expression of E- and P-cadherin during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. J Oral Pathol Med 32 (2003) 530-537
94. Vered M., Yarom N., and Dayan D. 4NQO oral carcinogenesis: animal models, molecular markers and future expectations. Oral Oncol 41 (2005) 337-339
95. Hellstrom K.E., Hellstrom I., and Brown J.P. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas. Int J Cancer 21 (1978) 317-322
96. Brown J.P., Klitzman J.M., Hellstrom I., Nowinski R.C., and Hellstrom K.E. Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci USA 75 (1978) 955-958
97. Fritze D., Kern D.H., Humme J.A., Drogemuller C.R., and Pilch Y.H. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens. Int J Cancer 17 (1976) 138-147
98. Dudley M.E., and Roopenian D.C. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens. J Exp Med 184 (1996) 441-447
99. Braakhuis B.J., Sneeuwloper G., and Snow G.B. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch Otorhinolaryngol 239 (1984) 69-79
100. Baker S.R. An in vivo model for squamous cell carcinoma of the head and neck. Laryngoscope 95 (1985) 43-56
101. Sales E.W., Fitch K.A., Sudetic P.A., Schechter G.L., Faulconer R.J., and Somers K.D. Growth and histopathology of human head and neck squamous cell carcinoma implanted intraorally in nude mice. Otolaryngol Head Neck Surg 104 (1991) 351-357
102. Simon C., Nemechek A.J., Boyd D., et al. An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion. Laryngoscope 108 (1998) 1686-1691
103. Hong F.D., and Clayman G.L. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res 60 (2000) 6551-6556
104. Eicher S.A., Clayman G.L., Liu T.J., et al. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin Cancer Res 2 (1996) 1659-1664
105. Dinesman A., Haughey B., Gates G.A., Aufdemorte T., and Von Hoff D.D. Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg 103 (1990) 766-774
106. Johnson J.I., Decker S., Zaharevitz D., et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84 (2001) 1424-1431
107. Alexander J.J., Bey E.M., Whitcutt J.M., and Gear J.H.S. Adaptation of cells derived from human malignant tumors to growth in vitro. S Afr J Med Sci 41 (1976) 89-98
108. Easty D.M., Easty G.C., Carter R.L., Monaghan P., and Butler L.J. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br J Cancer 43 (1981) 772-785
109. Odukoya O., Schwartz J., Weichselbaum R., and Shklar G. An epidermoid carcinoma cell line derived from hamster 7,12-dimethylbenz[a]anthracene-induced buccal pouch tumors. J Natl Cancer Inst 71 (1983) 1253-1264
110. Meng C.L., Shklar G., and Albright J. A transplantable anaplastic oral cancer model. Oral Surg Oral Med Oral Pathol 53 (1982) 179-189
111. Billingham R.E., and Hildemann W.K. Studies of transplantation immunity in hamsters. Ann N Y Acad Sci 73 (1958) 676-686
112. Billingham R.E., Ferrigan L.W., and Silvers W.K. Cheek pouch of the Syrian hamster and tissue transplantation immunity. Science 132 (1960) 1488
113. In: Van Hoosier G.L., and McPherson C.W. (Eds). Laboratory hamsters (1987), Academic Press Inc 218-219
114. Min B.M., Kim K., Cherrick H.M., and Park N.H. Three cell lines from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene, alone or in conjunction with herpes simplex virus inoculation. In Vitro Cell Dev Biol 27 (1991) 128-136
115. Thomas G.R., Chen Z., Oechsli M.N., Hendler F.J., and Van Waes C. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma. Int J Cancer 82 (1999) 377-384
116. O'Malley Jr. B.W., Cope K.A., Johnson C.S., and Schwartz M.R. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg 123 (1997) 20-24
117. Hirst D.G., Brown J.M., and Hazlehurst J.L. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer 46 1 (1982) 109-116
118. Cui N., Nomura T., Noma H., et al. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 11 (2005) 2713-2719
119. Fu K.K., Rayner P.A., and Lam K.N. Modification of the effects of continuous low-dose radiation by concurrent chemotherapy infusion. Int J Radiat Oncol Biol Phys 10 (1984) 1473-1478
120. Khurana D., Martin E.A., Kasperbauer J.L., et al. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck 23 (2001) 899-906
121. Mandpe A.H., Tsung K., and Norton J.A. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H. Mice Arch Otolaryngol Head Neck Surg 129 (2003) 786-792
122. Schantz S.P., Shillitoe E.J., Brown B., and Campbell B. Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 77 (1986) 869-875
123. Lou E., Kellman R.M., Hutchison R., and Shillitoe E.J. Clinical and pathological features of the murine AT-84 orthotopic model of oral cancer. Oral Diseases 9 (2003) 305-312
124. Fidler I.J. Critical factors in the biology of human cancer metastases: twenty eighth G.H.A Clowes memorial Award Lecture. Cancer Res 50 (1990) 6130-6138
125. Kuo T.-H., Kubota T., Watanabe M., et al. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: The importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 13 (1993) 627-630
126. Killion J.J., Radinsky R., and Fidler I.J. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Met Rev 7 (1999) 279-284
127. Yang M., Jiang P., Sun F.X., et al. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 59 (1999) 781-786
128. Rosol T.J., Tannehill-Gregg S.H., LeRoy B.E., Mandl S., and Contag C.H. Animal models of bone metastasis. Cancer 97 (2003) 748-757
129. Pasqualini R., and Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 380 (1996) 364-366
130. Gleich L.L., Li Y.Q., Li S., Gluckman J.L., and Stambrook P.J. Alloantigen gene therapy for head and neck cancer: evaluation of animal models. Head Neck 25 (2003) 274-279
131. Frijhoff A.F., Conti C.J., and Senderowicz A.M. Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs. Mol Carcinog 39 (2004) 183-194
132. Hann B., and Balmain A. Building 'validated' mouse models of human cancer. Curr Opin Cell Biol 13 (2001) 778-784
133. Nunez F., Dominguez O., Coto E., Suarez-Nieto C., Perez P., and Lopez-Larrea C. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck. Surg Oncol 1 (1992) 405-411
134. Anderson J.A., Irish J.C., McLachlin C.M., and Ngan B.Y. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 120 (1994) 755-760
135. Williams H.K. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 53 (2000) 165-172
136. Saranath D., Chang S.E., Bhoite L.T., et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63 (1991) 573-578
137. Vitale-Cross L., Amornphimoltham P., Fisher G., Molinolo A.A., and Gutkind J.S. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 64 (2004) 8804-8807
138. Redman R.S., Katuri V., Tang Y., Dillner A., Mishra B., and Mishra L. Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice. J Oral Pathol Med 34 (2005) 23-29
139. Caulin C., Nguyen T., Longley M.A., Zhou Z., Wang X.J., and Roop D.R. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 64 (2004) 5054-5058
140. http://cancermodels.nci.nih.gov/mmhcc/searchResultsDetail.jsp?modelId=2337.
141. Opitz O.G., Harada H., Suliman Y., et al. A mouse model of human oral-esophageal cancer. J Clin Invest 110 (2002) 761-769
142. Nakagawa H., Wang T.C., Zukerberg L., et al. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 14 (1997) 1185-1190
143. Ide F., Oda H., Nakatsuru Y., et al. Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis. Carcinogenesis 22 (2001) 567-572
144. Ide F., Kitada M., Sakashita H., and Kusama K. Reduction of p53 dosage renders mice hypersensitive to 7,12-dimethylbenz(alpha)anthracene-induced salivary gland tumorigenesis. Anticancer Res 23 (2003) 201-204
145. Ide F., Kitada M., Sakashita H., Kusama K., Tanaka K., and Ishikawa T. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 163 (2003) 1729-1733
146. Pérez M.A., Raimondi A.R., and Itoiz M.E. An experimental model to demonstrate the carcinogenic action of oral chronic traumatic ulcer. J Oral Pathol Med 34 (2005) 17-22
147. Take Y., Umeda M., Teranobu O., and Shimada K. Lymph node metastases in hamster tongue cancer induced with 9,10-dimethyl-1,2-benzanthracene (DMBA): association between histologic findings and the incidence of neck metastases, and the clinical implications for patients with tongue cancer. Br J Oral Maxillofac Surg 37 (1999) 29-36
148. Prime S.S., Eveson J.W., Stone A.M., et al. Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1. J Pathol 203 (2004) 927-932
149. Umeda M., Yokoo S., Komori T., Nishimatsu N., Shibuya Y., and Fujioka M. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. Br J Oral Maxillofac Surg 39 (2001) 376-380
150. Myers J.N., Holsinger F.C., Jasser S.A., Bekele B.N., and Fidler I.J. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 28 (2002) 293-298
151. Hori T., Yamashita Y., Ohira M., Matsumura Y., Muguruma K., and Hirakawa K. A novel orthotopic implantation model of human esophageal carcinoma in nude rats: CD44H mediates cancer cell invasion in vitro and in vivo. Int J Cancer 92 (2001) 489-496
152. Chen Z., Smith C.W., Kiel D., and Van Waes C. Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin Exp Metastasis 15 (1997) 527-537
153. Djalilian H.R., Lessan K., Grami V., et al. A new immune-competent animal model of mucosally derived squamous cell carcinoma. Otolaryngol Head Neck Surg 131 (2004) 781-783
154. van Es R.J.J., Dullens H.F.J., van der Bilt A., Koole R., and Slootweg P.J. Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J Craniomaxillofac Surg 28 (2000) 300-307
155. Chang C., and Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11 (2001) S37-S43
156. Wong R.J., Chan M.K., Yu Z., et al. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12. Clin Cancer Res 10 (2004) 4509-4516
157. Teknos T.N., Islam M., Arenberg D.A., et al. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 131 (2005) 204-211
158. Riedel F., Gotte K., Hormann K., and Grandis J.R. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy. Adv Otorhinolaryngol 62 (2005) 103-120
159. Imagawa Y., Satake K., Kato Y., Tahara H., and Tsukuda M. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model. Auris Nasus Larynx 31 (2004) 239-245
160. Traxler P., Allegrini P.R., Brandt R., et al. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res 64 (2004) 4931-4941
161. Brown M.D., Hudlicka O., Damon D., and Duling B.R. Vasoactive effects of basic and acidic fibroblast growth factors in hamster cheek pouch arterioles. Int J Microcirc Clin Exp 16 (1996) 308-312
162. Svensjo E., Boschcov P., Ketelhuth D.F., Jancar S., and Gidlund M. Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins. Inflamm Res 52 (2003) 215-220
163. Figueroa X.F., Gonzalez D.R., Martinez A.D., Duran W.N., and Boric M.P. ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J Physiol 544 (2002) 883-896
164. Jackson E.L., Willis N., Mercer K., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15 (2001) 3243-3248
165. Hotz H.G., Hines O.J., Foitzik T., and Reber H.A. Animal models of exocrine pancreatic cancer. Int J Colorectal Dis 15 (2000) 136-143
166. Stakleff K.D., and Von Gruenigen V.E. Rodent models for ovarian cancer research. Int J Gynecol Cancer 13 (2003) 405-412
167. Marx J. Medicine. Building better mouse models for studying cancer. Science 299 (2003) 1972-1975
168. Kwak I., Tsai S.Y., and DeMayo F.J. Genetically engineered mouse models for lung cancer. Annu Rev Physiol 66 (2004) 647-663
169. Leethanakul C., Patel V., Gillespie J., et al. Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol 36 (2000) 474-483
170. Shillitoe E.J., May M., Patel V., et al. Genome-wide analysis of oral cancer-early results from the Cancer Genome Anatomy Project. Oral Oncol 36 (2000) 8-16
171. Leethanakul C., Knezevic V., Patel V., et al. Head and Neck Cancer Genome Anatomy Project. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 39 (2003) 248-258
172. Jeon G.A., Lee J.S., Patel V., et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer 112 (2004) 249-258